Abnormal ultrasound finding after Capromorelin (Entyce) in dogs

54 reports to the FDA describe abnormal ultrasound finding in dogs given Capromorelin. That is 3.6% of all reports for this medicine, compared with 0.5% across reports for all dog medicines, so it is reported unusually often with this medicine.

54Reports
89%Marked serious
13%Recovered
30%Died or euthanised
7 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
12 27%
1–2 days
8 18%
3–7 days
3 6.8%
1–4 weeks
9 20%
Over a month
12 27%

How the animals did

Recovered
6 11%
Recovered with lasting effects
1 1.9%
Still unwell when reported
14 26%
Died
6 11%
Euthanised
10 19%
Not known
17 31%

Problems reported at the same time

Loss of appetite
38 70%
Liver problems
34 63%
Lethargy
31 57%
Kidney problems
29 54%
Vomiting
26 48%
Diarrhea
18 33%
Abnormal radiograph finding
17 31%
Death
16 30%

Age of the animals

Under 1 year
1
1–3 years
2
4–7 years
21
8–11 years
20
12+ years
10

About this medicine

Capromorelin stimulates appetite.

Products with this ingredient include Entyce, Elura. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Capromorelin cause abnormal ultrasound finding in dogs?
54 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 7 days of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Abnormal ultrasound finding with similar medicines

All reported side effects of Capromorelin in dogs · Medicines most reported with abnormal ultrasound finding